Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

15 mai 2025 10h04 HE | Source: ADvantage Therapeutics, Inc.

Klothea Bio Collaborates with Healthy Longevity Clinic, a Top 40 Semifinalist in $101 million XPRIZE Healthspan Competition

MIAMI, May 15, 2025 (GLOBE NEWSWIRE) -- Klothea Bio Inc., a biotechnology company pioneering mRNA-based therapies to upregulate the anti-aging protein Klotho, today announced its ongoing...
25 nov. 2024 09h41 HE | Source: ADvantage Therapeutics, Inc.

Advantage Therapeutics Inc. Announces Formation of Klothea Bio, Inc. to Advance Research and Development of Klotho Protein for Age-Related Therapeutics

MIAMI, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Advantage Therapeutics Inc., a leader in developing therapies targeting age-related diseases, announced today the formation of its new subsidiary, Klothea...
09 sept. 2024 10h01 HE | Source: ADvantage Therapeutics, Inc.

ADvantage Therapeutics, Inc. Welcomes Dr. William A. Haseltine as Strategic Advisor to Drive Innovation in Alzheimer's Disease Research and Anti-aging Therapies such as Klotho Protein Supplementation to Extend Healthy Human Lifespan

MIAMI, Sept. 09, 2024 (GLOBE NEWSWIRE) -- ADvantage Therapeutics, Inc., a leading clinical-stage biotechnology company dedicated to the advancement of innovative therapies for Alzheimer's disease,...
02 oct. 2023 10h43 HE | Source: Advantage Therapeutics Inc.

ADvantage Therapeutics Welcomes Esteemed Expert in Alzheimer’s Disease and Klotho Protein, Carmela Abraham, Ph.D. as Chief Science Officer

ADvantage Therapeutics appoints Dr. Carmela Abraham as Chief Science Officer